The strategy for detecting prostate cancer has undergone drastic changes in the past two decades. Serum prostatespecific antigen (PSA) test has became widely available for screening of prostate cancer. Transrectal ultrasonography is now routinely used in guiding systemic prostate biopsies. Along with excellent surgical outcomes from an improved understanding of pelvic anatomy and modified surgical techniques,1 early detection of prostate cancer has contributed to the improved outcomes of men with prostate cancer. In this chapter, we review a brief history of the current detection strategy for prostate cancer; then we review potential new markers for prostate cancer screening and detection. Finally, we discuss the rationale and results of early detection of prostate cancer.
|Original language||English (US)|
|Title of host publication||Prostate Cancer|
|Subtitle of host publication||Principles and Practice|
|Number of pages||11|
|State||Published - Jan 1 2005|
ASJC Scopus subject areas